Comparison of the Efficacy and Safety of Low Molecular Weight Heparins and Unfractionated Heparin in the Initial Treatment of Deep Venous Thrombosis

This publication has 17 references indexed in Scilit:

• A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis
  New England Journal of Medicine, 1996
• Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home
  New England Journal of Medicine, 1996
• Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
  New England Journal of Medicine, 1995
• Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis
  BMJ, 1994
• A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicentre study.
  1991
• Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.
  Circulation, 1989
• [Treatment of deep venous thrombosis. Comparative study of a low molecular weight heparin fragment (Fragmin) by the subcutaneous route and standard heparin by the continuous intravenous route. A multicenter study].
  1989
• Deep Vein Thrombosis of the Legs: New Therapy by Mean of Low Molecular Weight Heparins
  Journal of International Medical Research, 1988
• A NEW TREATMENT OF DEEP-VEIN THROMBOSIS - LOW-MOLECULAR WEIGHT HEPARIN FRACTIONS - A RANDOMIZED COMPARATIVE-STUDY
  1988
• ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISM
  The Lancet, 1960